Scientists at Klick Applied Sciences say they discovered a way to use a continuous glucose monitor (CGM) as a diabetes screening tool.
The scientists determined that they can use artificial intelligence (AI) to screen and prevent diabetes. They used machine learning and 12 hours of data from CGMs to determine whether a patient had prediabetes or diabetes.
“We have demonstrated that 12 hours of monitoring can make a big difference in the lives of people at risk of developing diabetes while there’s still time to course correct,” said Jouhyun Jeon, lead scientist of the study and principal investigator at Klick Applied Sciences. “We think CGMs could be used to not just monitor diabetes – but to prevent it altogether.”
Get the full story at our sister site, Drug Delivery Business News.